Skip to main content

Table 2 Median time delays from negative smear microscopy to TB treatment through positive Xpert test among pulmonary TB/HIV co-infected patients during 2015 in Beira city, Mozambique

From: Time delay and associated mortality from negative smear to positive Xpert MTB/RIF test among TB/HIV patients: a retrospective study

Characteristics

Delays in TB diagnosis and Treatment (DAYS)

From NSSM to PXTBt

From PXTBt to TB Treatment initiation

From NSSM to TB Treatment initiation

Median (IQR)

Median (IQR)

Median (IQR)

Sex

 Male

9 (13)

14 (14)

30 (23)

 Female

7.5 (8)

13 (11)

26 (19)

p-value (Mann-Whitney U)

0.127

0.579

0.364

Age groups

 15–24 years old

7 (7)

13 (13)

27 (21)

 25–34 years old

9 (11)

14 (11)

29 (17)

 35–44 years old

9 (9)

13 (15)

27 (20)

 45–54 years old

12.5 (14)

14 (10)

33.5 (26)

  > 55 years old

11 (7)

12 (6)

25 (15)

p-value (Kruskal-Wallis)

0.303

0.905

0.585

TB treatment center

 Ponta-Gea

5 (12)

8 (4)

13 (23)

 Macurungo

13 (8)

13 (12)

26 (10)

 Manga Mascarenha

11 (8)

17 (8)

33.5 (20)

 Munhava

11 (10)

15 (12)

32 (12)

 Nhaconjo

12 (13)

14 (9)

27 (11)

 Chingussura

13 (22)

15.5 (9)

36 (24)

p-value (Kruskal-wallis)

0.001

0.001

0.001

TB treatment outcome

 Completed

7 (9)

10 (11)

23 (19)

 Died

11 (10)

14.5 (12)

31.5 (20)

p-value (Mann-Whitney U)

0.013

0.001

0.001

WHO clinical satage of HIV

 Stage 3

9 (8)

11 (11)

22 (15)

 Stage 4

7 (13)

19 (13)

25 (21)

p-value (Mann-Whitney U)

0.947

0.002

0.004

Total

10 (9)

13 (12)

28 (20)

  1. IQR = Interquartile range, NSSM = Negative Sputum Smear Microscopy, PXTBt = Positive Xpert TB test